To test whether seladin-1 could be epigenetically regulated also 'in vivo', promoter methylation and its mRNA expression were measured in 9 adrenal carcinomas and in 5 normal adrenal glands. The gene discussed is DHCR24; the disease is adrenal carcinoma.